MarilynTelenMD

Blood Banking & Transfusion Medicine, Sickle Cell & Other Anemias

Professor, Medicine, Duke University School of Medicine

Dr. Telen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Dr. Marilyn Telen, based in Durham, NC, specializes in Hematology with sub-specialities in Blood Banking & Transfusion Medicine and Sickle Cell & Other Anemias. A graduate of New York University School of Medicine in 1977, she completed her residency in Internal Medicine at University of Buffalo from 1977 to 1980 and a fellowship in Hematology and Immunohematology at Duke University 1980-1983. Her notable expertise includes sickle cell disease (basic, translational and clinical research and clinical practice), transfusion medicine, anemia, and autoimmune disorders, supported by many publications in high-impact journals. Dr. Telen has worked on numerous clinical trials, predominantly related to Sickle Cell Disease. Her work has led her to be recognized by the American Association of Physicians and The American Society for Clinical Investigation, and she has consistently been deemed one of America's Top Doctors by Castle Connolly.

Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis Start of enrollment: 2010 May 01
Completed
Phase 2
Effect of Broccoli Sprouts Homogenate on SS RBC Start of enrollment: 2012 Mar 01
Completed
Not Applicable
A Phase II Trial of Regadenoson in Sickle Cell Anemia Start of enrollment: 2013 Jul 01
Completed
Phase 2
Sickle Cell Disease and CardiovAscular Risk - Red Cell Exchange Trial (SCD-CARRE) Start of enrollment: 2020 Feb 26
Recruiting
Phase 3
Roles: Contact, Principal Investigator
Topical Sodium Nitrite in Sickle Cell Disease and Leg Ulcers Start of enrollment: 2018 Apr 06
Completed
Phase 2
Roles: Contact
Join now to see all

PubMed

The critical role of symptom experience on risk tolerance for gene therapy.
Juan Marcos Gonzalez Sepulveda, Shelby D Reed, Marilyn Telen
Blood Advances. 2024-11-12
Black Americans With Sickle Cell Disease (SCD) Demonstrate Accelerated Epigenetic Pace of Aging Compared to Black Americans Without SCD.
Melanie E Garrett, Brandon Le, Kyle J Bourassa, Michelle F Dennis, Daniel Hatch
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences. 2024-11-01
1 citations
Whole-genome sequencing in 333,100 individuals reveals rare non-coding single variant and aggregate associations with height.
Gareth Hawkes, Robin N Beaumont, Zilin Li, Ravi Mandla, Xihao Li
Nature Communications. 2024-10-03

Abstracts/Posters

Identification of Optimal Thalassemia Screening Strategies for Migrant Populations in Thailand: A Mixed-Methods Approach
Marilyn J. Telen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Phase 1 Single (SAD) and Multiple Ascending Dose (MAD) Studies of the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of FT-4202, an Allosteric A...
Marilyn J. Telen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

Knowledge, Cultural, and Structural Barriers to Thalassemia Screening in Migrant Populations in Thailand
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Forma Therapeutics Announces Presentations at Upcoming Hematology ConferencesJune 10th, 2022
Biomedicine: Speeding up Sickle Cell TreatmentMarch 17th, 2017